Drugs / TVAV-008
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07282249 | Dec 2025 → Apr 2027 expected | chronic hepatitis B virus infection | Grand Theravac Life Sciences (Nanjing) Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TVAV-008 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07282249 ↗ |